Literature DB >> 23793814

Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas.

Ata Türker Arikök1, Evrim Onder, Hakan Seçkin, Ayper Kaçar, Ramazan Fesli, Ayşe Selcen Oğuz, Murat Alper.   

Abstract

Recurrence of meningiomas is a major prognostic issue. Although World Health Organization (WHO) histopathological grading correlates strongly with recurrence, it has some limitations, and predicting the biological behavior of grade I meningiomas is particularly difficult. Osteopontin (OPN) is a protein known to be involved in tumor progression. The purpose of this study is to determine expression of OPN in meningiomas and to investigate its correlation with WHO grades and tumor recurrence. Immunohistochemical (IHC) evaluation of expression of OPN was performed by two different methods to ensure reliability. OPN IHC and Allred scores were calculated on the basis of intensity and extent of staining. Both scores were in agreement and correlated significantly with meningioma grade and Ki-67 index. OPN scores were also significantly correlated with recurrence of WHO grade I meningiomas. Cut-off values for OPN IHC and OPN Allred scores between non-recurrent and recurrent grade I meningiomas were calculated as 70 and 5.5 respectively. We concluded that OPN is a valuable marker for grading meningiomas and for predicting the recurrence in WHO grade I tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793814     DOI: 10.1007/s10014-013-0152-2

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  3 in total

1.  Are Osteopontin and Ki67 Expressions Different in Various Histologic Grades of Meningioma? An Iranian Experience.

Authors:  Forough Hashemi; Pegah Babaheidarian; Soheila Dabiran
Journal:  Iran J Pathol       Date:  2015

2.  Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.

Authors:  Yi-Peng Han; Chen-Kai Ma; Shen-Qi Wang; Atsushi Enomoto; Yang Zhao; Masahide Takahashi; Jie Ma
Journal:  J Neurooncol       Date:  2014-05-31       Impact factor: 4.130

Review 3.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.